Pluri Inc.
PLUR
$4.72
$0.11412.48%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/5/2025
-
The Fly
3/5/2025
-
GuruFocus
3/5/2025
-
Globe Newswire
2/19/2025
-
Ticker Report
2/19/2025
-
Globe Newswire
2/11/2025
-
TipRanks Financial Blog
2/11/2025
-
TipRanks Financial Blog
2/5/2025
-
Ticker Report
2/4/2025
-
Seeking Alpha - Israel Stocks
2/4/2025
-
Seeking Alpha - Healthcare
2/4/2025
-
TipRanks Financial Blog
2/4/2025
-
The Fly
2/4/2025
-
GuruFocus
2/4/2025
-
Globe Newswire
1/29/2025
-
TipRanks Financial Blog
1/23/2025
-
The Fly
1/23/2025
-
GuruFocus
1/23/2025
-
The Fly
1/23/2025
-
Globe Newswire
1/13/2025
-
Ticker Report
12/31/2024
-
Ticker Report
12/19/2024
-
The Fly
12/19/2024
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 74 710 8600
Address
Building No. 5
Haifa, 3508409
Haifa, 3508409
Country
Year Founded
Business Description
Sector
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It...
more